Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis.

Moratalla A, Gómez-Hurtado I, Moya-Pérez Á, Zapater P, Peiró G, González-Navajas JM, Gómez Del Pulgar EM, Such J, Sanz Y, Francés R.

Eur J Nutr. 2015 Feb 6. [Epub ahead of print]

PMID:
25657013
2.

Gut microbiota-related complications in cirrhosis.

Gómez-Hurtado I, Such J, Sanz Y, Francés R.

World J Gastroenterol. 2014 Nov 14;20(42):15624-31. doi: 10.3748/wjg.v20.i42.15624.

3.

Understanding the role of gut microbiome in metabolic disease risk.

Sanz Y, Olivares M, Moya-Pérez Á, Agostoni C.

Pediatr Res. 2015 Jan;77(1-2):236-44. doi: 10.1038/pr.2014.170. Epub 2014 Oct 14.

PMID:
25314581
4.

Impaired responses to gliadin and gut microbes of immune cells from mice with altered stress-related behavior and premature immune senescence.

De Palma G, Vida C, Santacruz A, De Castro NM, De la Fuente M, Sanz Y.

J Neuroimmunol. 2014 Nov 15;276(1-2):47-57. doi: 10.1016/j.jneuroim.2014.08.007. Epub 2014 Aug 13.

PMID:
25176132
5.

Microbiota, inflammation and obesity.

Sanz Y, Moya-Pérez A.

Adv Exp Med Biol. 2014;817:291-317. doi: 10.1007/978-1-4939-0897-4_14. Review.

PMID:
24997040
6.

High-protein diet modifies colonic microbiota and luminal environment but not colonocyte metabolism in the rat model: the increased luminal bulk connection.

Liu X, Blouin JM, Santacruz A, Lan A, Andriamihaja M, Wilkanowicz S, Benetti PH, Tomé D, Sanz Y, Blachier F, Davila AM.

Am J Physiol Gastrointest Liver Physiol. 2014 Aug 15;307(4):G459-70. doi: 10.1152/ajpgi.00400.2013. Epub 2014 Jun 26.

PMID:
24970777
7.

The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease.

Olivares M, Neef A, Castillejo G, Palma GD, Varea V, Capilla A, Palau F, Nova E, Marcos A, Polanco I, Ribes-Koninckx C, Ortigosa L, Izquierdo L, Sanz Y.

Gut. 2015 Mar;64(3):406-17. doi: 10.1136/gutjnl-2014-306931. Epub 2014 Jun 17.

PMID:
24939571
8.

Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis.

Gómez-Hurtado I, Moratalla A, Moya-Pérez Á, Peiró G, Zapater P, González-Navajas JM, Giménez P, Such J, Sanz Y, Francés R.

J Hepatol. 2014 Oct;61(4):799-808. doi: 10.1016/j.jhep.2014.05.031. Epub 2014 Jun 2.

PMID:
24882049
9.

Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease.

Olivares M, Castillejo G, Varea V, Sanz Y.

Br J Nutr. 2014 Jul 14;112(1):30-40. doi: 10.1017/S0007114514000609. Epub 2014 Apr 28.

PMID:
24774670
10.

Antibiotic exposure in pregnancy and risk of coeliac disease in offspring: a cohort study.

Mårild K, Ludvigsson J, Sanz Y, Ludvigsson JF.

BMC Gastroenterol. 2014 Apr 14;14:75. doi: 10.1186/1471-230X-14-75.

11.

Combining motivational and volitional strategies to promote unsupervised walking in patients with fibromyalgia: study protocol for a randomized controlled trial.

Pastor MÁ, López-Roig S, Lledó A, Peñacoba C, Velasco L, Schweiger-Gallo I, Cigarán M, Ecija C, Limón R, Sanz Y.

Trials. 2014 Apr 11;15:120. doi: 10.1186/1745-6215-15-120.

12.

Human milk composition differs in healthy mothers and mothers with celiac disease.

Olivares M, Albrecht S, De Palma G, Ferrer MD, Castillejo G, Schols HA, Sanz Y.

Eur J Nutr. 2015 Feb;54(1):119-28. doi: 10.1007/s00394-014-0692-1. Epub 2014 Apr 4.

PMID:
24700375
13.

Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis.

Moratalla A, Gómez-Hurtado I, Santacruz A, Moya Á, Peiró G, Zapater P, González-Navajas JM, Giménez P, Such J, Sanz Y, Francés R.

Liver Int. 2014 Jul;34(6):850-8. doi: 10.1111/liv.12380. Epub 2013 Nov 24.

PMID:
24267920
14.

Future for probiotic science in functional food and dietary supplement development.

Neef A, Sanz Y.

Curr Opin Clin Nutr Metab Care. 2013 Nov;16(6):679-87. doi: 10.1097/MCO.0b013e328365c258. Review.

PMID:
24071779
15.

Probiotics and clinical effects: is the number what counts?

Bertazzoni E, Donelli G, Midtvedt T, Nicoli J, Sanz Y.

J Chemother. 2013 Aug;25(4):193-212. doi: 10.1179/1973947813Y.0000000078. Review.

PMID:
23906073
16.

Duodenal-mucosal bacteria associated with celiac disease in children.

Sánchez E, Donat E, Ribes-Koninckx C, Fernández-Murga ML, Sanz Y.

Appl Environ Microbiol. 2013 Sep;79(18):5472-9. doi: 10.1128/AEM.00869-13. Epub 2013 Jul 8.

17.

Hepatic molecular responses to Bifidobacterium pseudocatenulatum CECT 7765 in a mouse model of diet-induced obesity.

Moya-Pérez A, Romo-Vaquero M, Tomás-Barberán F, Sanz Y, García-Conesa MT.

Nutr Metab Cardiovasc Dis. 2014 Jan;24(1):57-64. doi: 10.1016/j.numecd.2013.04.011. Epub 2013 Jul 4.

PMID:
23831006
18.

Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study.

Pozo-Rubio T, de Palma G, Mujico JR, Olivares M, Marcos A, Acuña MD, Polanco I, Sanz Y, Nova E.

Nutr Hosp. 2013 Mar-Apr;28(2):464-73. doi: 10.3305/nh.2013.28.2.6310.

19.

Oral administration of Bifidobacterium longum CECT 7347 ameliorates gliadin-induced alterations in liver iron mobilisation.

Laparra JM, Olivares M, Sanz Y.

Br J Nutr. 2013 Nov;110(10):1828-36. doi: 10.1017/S0007114513001098. Epub 2013 May 9.

PMID:
23657133
20.

Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice.

Cano PG, Santacruz A, Trejo FM, Sanz Y.

Obesity (Silver Spring). 2013 Nov;21(11):2310-21. doi: 10.1002/oby.20330. Epub 2013 May 29.

PMID:
23418126
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk